Status:
COMPLETED
ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborating Sponsors:
Teva Neuroscience, Inc.
H. Lundbeck A/S
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
Eligible participants, who participated in the ADAGIO trial and who sign an approved informed consent form, will be enrolled into the study at their original study locations. participants who have sto...
Eligibility Criteria
Inclusion
- Subjects who participated in the ADAGIO study, and who entered the active phase of the study and
- Subjects who are currently on rasagiline treatment (or subjects who have stopped rasagiline treatment, are willing to restart treatment, and in the opinion of the investigator will gain clinical benefit from restarting treatment) and
- Subjects with a diagnosis of Parkinson's disease and
- Subjects willing and able to give written informed consent
Exclusion
- Subjects who have discontinued rasagiline treatment due to an adverse event and have not restarted rasagiline treatment subsequently.
- Subjects who cannot be given rasagiline due to any exclusion based on the local label (including pregnancy or nursing women) or due to the use of medications contraindicated for concomitant use with rasagiline according to local label
- Subjects with a medical condition that is considered by the investigator as significant enough to prevent participation
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
684 Patients enrolled
Trial Details
Trial ID
NCT00936676
Start Date
July 1 2009
End Date
March 1 2013
Last Update
April 11 2016
Active Locations (102)
Enter a location and click search to find clinical trials sorted by distance.
1
Teva Investigational Site 7054
Birmingham, Alabama, United States
2
Teva Investigational Site 7006
Tucson, Arizona, United States
3
Teva Investigational Site 7018
Irvine, California, United States
4
Teva Investigational Site 7019
La Jolla, California, United States